This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Université De Sherbrooke, Eli Lilly and Company, Societe De Commercialisation Des Produits De La Recheche Appliquee-Socpra-Science Sante Et Humaines S.e.c.. Active years: 2006-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chomedey, CA (2006)
- Sherbrooke, CA (2007 - 2022)
Company Filing History:
2 out of 67 
1 out of 4,517 
1 out of 1 Years Active: 2006-2025
Title: Fernand Gobeil: Innovator in Pharmaceutical and Cancer Research
Introduction
Fernand Gobeil is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the fields of pharmaceuticals and cancer research. With a total of 5 patents, Gobeil's work focuses on improving medical treatments and patient outcomes.
Latest Patents
Gobeil's latest patents include innovative solutions aimed at enhancing insulin absorption and addressing cancer treatment. One of his patents, titled "Pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin," relates to compositions that combine insulin with vasoactive agents. This invention aims to increase subcutaneous insulin absorption and treat diabetes effectively. Another significant patent is "Kinin-based theranostic probes for solid cancers and uses thereof." This patent introduces new chemical entities that allow for simultaneous diagnosis and treatment of cancers, utilizing a theranostic compound that targets kinin B1 receptors.
Career Highlights
Throughout his career, Gobeil has worked with esteemed organizations such as Université De Sherbrooke and Eli Lilly and Company. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.
Collaborations
Gobeil has collaborated with notable colleagues, including Witold A Neugebauer and Domenico Regoli. These partnerships have further enriched his research and innovation efforts.
Conclusion
Fernand Gobeil's contributions to pharmaceutical and cancer research highlight his dedication to improving healthcare solutions. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile